Maxwell Jane Carlisle
The Gulf Coast Addiction Technology Transfer Center, The School of Social Work, The University of Texas at Austin, Austin, Texas 78703, USA.
Subst Use Misuse. 2005;40(9-10):1203-40. doi: 10.1081/JA-200066736.
This review summarizes the latest literature on "party" or "club" drugs, defined as MDMA, GHB, ketamine, and Rohypnol, as published from 2002 to early 2005. Club drugs have been categorized as being used at raves and dance parties. The literature shows that each drug has different properties, users, and settings. Each drug has different adverse effects and requires different acute care protocols. Although these drugs were identified early, scientific information about them, including the toxicological tests to identify them, is still evolving. Increasing numbers of studies on the short- and long-term effects of these drugs on humans are being published, but because of limitations on research using human subjects, they may not always be as rigorous as desired and can be cited by drug users to discredit findings of harm. The lack of research-based information on these drugs has led to the emergence of web sites that may or may not provide accurate data. Evaluated chemical dependency treatment protocols using the latest research for each of these different drugs are needed.
本综述总结了2002年至2005年初发表的关于“派对”或“俱乐部”药物（定义为摇头丸、γ-羟基丁酸、氯胺酮和氟硝西泮）的最新文献。俱乐部药物被归类为在锐舞派对和舞蹈派对上使用的药物。文献表明，每种药物都有不同的特性、使用者和使用场景。每种药物都有不同的不良反应，需要不同的急性护理方案。尽管这些药物很早就被发现了，但关于它们的科学信息，包括用于识别它们的毒理学测试，仍在不断发展。越来越多关于这些药物对人类短期和长期影响的研究正在发表，但由于使用人类受试者进行研究存在局限性，这些研究可能并不总是如预期的那样严谨，并且可能被吸毒者引用以诋毁危害研究结果。关于这些药物缺乏基于研究的信息导致了一些网站的出现，这些网站提供的数据可能准确也可能不准确。需要根据最新研究为每种不同药物评估化学依赖治疗方案。
